Gene set enrichment analysis (GSEA) revealed that immune and tumor-related pathways, such as primary immunodeficiency, T cell receptor signaling pathway, intestinal immune network for IgA production, hematopoietic cell lineage, type I diabetes mellitus, allograft rejection, cytokine-cytokine receptor interaction, antigen processing and presentation, graft-versus-host disease, chemokine signaling pathway, and natural killer cell-mediated cytotoxicity, showed appropriate hallmarks of regulation in the low-risk group (Figure S3 and Table S4). Here, CD79A is linked to graft versus host disease.